Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.
about
The PI3K/Akt Pathway in Tumors of Endocrine TissuesThe roles of PDGF in development and during neurogenesis in the normal and diseased nervous systemRole of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytomaAutophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian CarcinomaDistinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentTyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors.Autophagic action of new targeting agents in head and neck oncology.Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro.Capsaicin induces apoptosis in PC12 cells through ER stress.Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function.Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017)
P2860
Q26770404-29E2C1CC-FE0E-41F2-9A77-FF9FE425DA53Q26852944-7A079A77-E46B-450B-B1BE-37A2749ABE3CQ33580374-A101CF0A-280D-47AD-AB92-2469973593D0Q33746474-48F88205-2F5B-4FAA-A79C-F7B509849D67Q33801399-3AEBA197-A365-4B52-A91A-61F3ECA8C5B4Q34410500-89289A79-7492-417A-B188-284D7A1D7F05Q37159039-FEE8ACB6-73BB-4D42-9181-5893E6788C40Q37470890-B223833C-F0F7-4B2A-9858-2D6B48AA2C7BQ37660355-9395CB4F-4CE4-419F-86B2-BA2A77F0AC6CQ38028794-E1C411DD-EDC1-44ED-92DC-5BF7DB1DFD6EQ38821658-01A282BF-7114-4299-A2D8-363DAE7ABA17Q39043518-D1D8D8FF-28B4-47FD-B8E6-C78AD44FF4C7Q39183426-6A8AB05E-B1F3-4E32-B405-0532B3797853Q39293265-3FFB1B02-93DA-4748-B477-B90D01BCC6F0Q46631747-D5DCA5C1-DCE3-4D4B-9DAB-835D51A0B9C6Q57652261-476CCEC6-7664-4E46-9AED-090B5F20761B
P2860
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@en
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@nl
type
label
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@en
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@nl
prefLabel
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@en
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@nl
P2093
P2860
P1476
Sunitinib induces apoptosis in ...... h modulation of Bcl-2 and BAD.
@en
P2093
Hisato Hara
Hitoshi Shimano
Kazuhiro Takekoshi
Kazumasa Isobe
Kiyo-Aki Ishii
Tatsuhiko Ikeda
Yasushi Kawakami
Yuichi Aita
Yuko Tanaka
Yuria Saito
P2860
P304
P356
10.1152/AJPENDO.00035.2011
P577
2011-08-30T00:00:00Z